What is it? Any common name for this procedure?
These "procedures" are advanced medical treatment protocols involving Direct-Acting Antivirals (DAAs) for Hepatitis C and Nucleos(t)ide Analogues (NAs) or newer Antisense Oligonucleotides (ASOs) for Hepatitis B. While often referred to simply as "Antiviral Therapy," the goal for Hepatitis C is a complete "viral clearance" or cure, while for Hepatitis B, the focus is shifting toward a "Functional Cure".
Common Names: DAA Therapy (for Hep C), Chronic HBV Management, or "Functional Cure Protocol" (specifically for newer HBV drugs like Bepirovirsen).
2. Common Symptoms for Medical Consultation
Hepatitis is often called a "silent" disease because many patients exhibit no symptoms until liver damage is advanced. You should consult a doctor if you experience:
- Jaundice: Yellowing of the skin or the whites of the eyes.
- Chronic Fatigue: Persistent, extreme tiredness not relieved by rest.
- Abdominal Pain: Specifically in the upper right quadrant where the liver is located.
- Dark Urine and Pale Stools: Changes in waste color indicating bile processing issues.
- Loss of Appetite and Nausea: Frequent upset stomach or unexplained weight loss.
- Joint and Muscle Pain: Often mistaken for the flu or arthritis.
3. List of Associated Diseases
If left untreated, chronic Hepatitis B and C can lead to severe systemic and localized health complications:
- Cirrhosis: Extensive scarring of the liver tissue that impairs its function.
- Hepatocellular Carcinoma (HCC): A common type of primary liver cancer.
- Liver Failure: A life-threatening condition where the liver ceases to function.
- Non-Hodgkin Lymphoma: Specifically associated with chronic Hepatitis C infection.
- Kidney Disease: Inflammation of the kidneys caused by the body’s immune response to the virus.
- Vasculitis: Inflammation of the blood vessels.
4. List of Screening Tests
Before starting therapy, a series of diagnostic "screening procedures" are performed to identify the viral strain and liver health:
- Hepatitis B Surface Antigen (HBsAg): Determines if you are currently infected with HBV.
- HCV Antibody Test: Screens for the presence of antibodies to the Hepatitis C virus.
- HCV RNA (Viral Load): Confirms active infection and measures the amount of virus in the blood.
- Liver Function Tests (LFTs): Measures enzymes like ALT and AST to assess current liver inflammation.
- FibroScan (Transient Elastography): A non-invasive ultrasound-based test to measure liver stiffness (fibrosis).
- Genotype Testing: Determines the specific strain of the virus to select the most effective drug.
5. Am I Eligible for This Procedure?
Eligibility is determined by a hepatologist based on several factors:
- Chronic Status: Treatment is typically indicated for those whose infection has lasted longer than six months.
- Viral Load and Liver Damage: High levels of HBV DNA or evidence of significant liver scarring (F2 stage or higher) usually trigger treatment.
- Coinfections: Patients with HIV or Hepatitis D coinfections are prioritized due to higher risks of rapid liver damage.
- Age: Most modern therapies are now approved for adults and adolescents (aged 12+), with some pediatric options available.
- Specific Criteria for HBV: New therapies like Bepirovirsen are often targeted at patients with specific surface antigen levels (e.g., HBsAg ≤3000 IU/ml).
6. Pre and Post Care for This Procedure
Pre-Care:
- Medication Review: Inform your doctor of all supplements, as many (like St. John's Wort) interfere with antivirals.
- Alcohol Cessation: Total abstinence is required to prevent further liver stress.
- Vaccination: Patients should be vaccinated for Hepatitis A (if not immune) to prevent dual-virus complications.
Post-Care:
- Strict Adherence: Antivirals must be taken at the same time every day; missing doses can lead to drug resistance.
- SVR12 Monitoring: For Hep C, a blood test 12 weeks after finishing treatment confirms if the virus is truly "cured" (Sustained Virologic Response).
- Ongoing Screening: Even after a "cure" or viral suppression, patients with existing cirrhosis must continue liver cancer screening every six months.
7. Days Required for Hospitalization
Modern antiviral therapy is almost exclusively an outpatient procedure.
Duration: The treatment itself lasts between 8 to 12 weeks for Hepatitis C, while Hepatitis B may require long-term or lifelong daily medication.
Hospital Stay: 0 days (In-hospital stays are only required if a patient presents with acute liver failure or severe complications like variceal bleeding).
Disclaimer: As per doctor’s advice, the number of days for hospitalization or the duration of treatment may get modified based on individual health status.
8. Benefits of This Procedure
- Viral Eradication: Hepatitis C is now curable in over 95% of cases.
- Prevention of Cancer: Successfully suppressing or clearing the virus significantly reduces the risk of developing liver cancer.
- Reversal of Damage: In many cases, the liver can regenerate and fibrosis (scarring) can actually regress once the viral attack stops.
- Life Extension: Effective treatment lowers mortality rates and prevents the need for a liver transplant.
- Community Health: Achieving an undetectable viral load means the virus can no longer be transmitted to others.
